Therapeutic implications of biomarkers in chronic heart failure.

Therapeutic implications of biomarkers in chronic heart failure.

Item
http://www.wikidata.org/entity/Q38121720
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failureRelationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.The potential role of NT-proBNP in screening for and predicting prognosis in heart failure: a survival analysis.The Current and Potential Clinical Relevance of Heart Failure Biomarkers.Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HFHeart failure: a disease complex with challenging therapeutics.Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction.Establishment of normal reference values of NT-proBNP and its application in diagnosing acute heart failure in children with severe hand food and mouth disease
P2860

Therapeutic implications of biomarkers in chronic heart failure.

Item
http://www.wikidata.org/entity/Q38121720
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic implications of biomarkers in chronic heart failure.
@en
type
label
Therapeutic implications of biomarkers in chronic heart failure.
@en
prefLabel
Therapeutic implications of biomarkers in chronic heart failure.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Therapeutic implications of biomarkers in chronic heart failure.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921